Shenjie (monosialotetrahexosylganglioside sodium)
/ Qilu Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 14, 2026
A Study to Evaluate the Efficacy and Safety of Monosialotetrahexosylganglioside Sodium Injection in Parkinson's Disease Participants With Motor Fluctuations
(clinicaltrials.gov)
- P2 | N=276 | Not yet recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.
New P2 trial • CNS Disorders • Movement Disorders • Parkinson's Disease
1 to 1
Of
1
Go to page
1